Title: H.P. 357 House of Representatives, February 11, 2025
Official Title: H.P. 357 House of Representatives, February 11, 2025
Number of Sections: 1
Source: versions - Documents and Disposition
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
132nd MAINE LEGISLATURE
FIRST REGULAR SESSION-2025
Legislative Document No. 538
An Act to Amend Maine's Prescription Drug Labeling Law by
Allowing the Removal of the Name of a Prescriber of Mifepristone,
Misoprostol and Their Generic Alternatives
Reference to the Committee on Health Coverage, Insurance and Financial Services
suggested and ordered printed.
ROBERT B. HUNT
Clerk
Presented by Representative CLUCHEY of Bowdoinham.
Cosponsored by Senator CARNEY of Cumberland and
Representatives: Speaker FECTEAU of Biddeford, GRAMLICH of Old Orchard Beach,
JULIA of Waterville, KUHN of Falmouth, MATHIESON of Kittery, MOONEN of Portland,
WARREN of Scarborough, Senator: BAILEY of York.
Printed on recycled paper
1 Be it enacted by the People of the State of Maine as follows:
2 Sec. 1. 32 MRSA ยง13794, as amended by PL 2019, c. 34, ยง5, is further amended
3 by enacting at the end a new paragraph to read:
4 At the request of the practitioner prescribing the drug, the label for mifepristone,
5 misoprostol and their generic alternatives may include the name of the health care facility
6 that the practitioner is associated with instead of the name of the practitioner.
7 SUMMARY
88 This bill provides that, at the request of the practitioner prescribing the drug, the
99 prescription drug label for mifepristone, misoprostol and their generic alternatives may
1100 include the name of the health care facility that the practitioner is associated with instead
1111 of the name of the practitioner.
Page 1 - 132LR0749(01)
[DELETED: tN7H]
[DELETED: B bA t r o t p p t d t l f mmtT t p t dp0i1o]


================================================================================

Raw Text:
132nd MAINE LEGISLATURE
FIRST REGULAR SESSION-2025
Legislative Document No. 538
H.P. 357 House of Representatives, February 11, 2025
An Act to Amend Maine's Prescription Drug Labeling Law by
Allowing the Removal of the Name of a Prescriber of Mifepristone,
Misoprostol and Their Generic Alternatives
Reference to the Committee on Health Coverage, Insurance and Financial Services
suggested and ordered printed.
ROBERT B. HUNT
Clerk
Presented by Representative CLUCHEY of Bowdoinham.
Cosponsored by Senator CARNEY of Cumberland and
Representatives: Speaker FECTEAU of Biddeford, GRAMLICH of Old Orchard Beach,
JULIA of Waterville, KUHN of Falmouth, MATHIESON of Kittery, MOONEN of Portland,
WARREN of Scarborough, Senator: BAILEY of York.
Printed on recycled paper

1 Be it enacted by the People of the State of Maine as follows:
2 Sec. 1. 32 MRSA ยง13794, as amended by PL 2019, c. 34, ยง5, is further amended
3 by enacting at the end a new paragraph to read:
4 At the request of the practitioner prescribing the drug, the label for mifepristone,
5 misoprostol and their generic alternatives may include the name of the health care facility
6 that the practitioner is associated with instead of the name of the practitioner.
7 SUMMARY
88 This bill provides that, at the request of the practitioner prescribing the drug, the
99 prescription drug label for mifepristone, misoprostol and their generic alternatives may
1100 include the name of the health care facility that the practitioner is associated with instead
1111 of the name of the practitioner.
Page 1 - 132LR0749(01)

[DELETED: tN7H]
[DELETED: B bA t r o t p p t d t l f mmtT t p t dp0i1o]